Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Huh Hoyoung. Director active across 2 companies, notably Akari Therapeutics Plc. Aggregated, 13 reports have been published. Breakdown: 7 buys · 0 sell. Total volume traded: €1k. History available since 1 November 2022. The latest transaction was disclosed on 6 March 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Huh Hoyoung
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Huh Hoyoung is a declarant linked to Peak Bio, Inc. and Akari Therapeutics Plc, where he is a Director. He has 13 filings in total. In the recent filings tracked, they cover the period from 2022-11-03 to 2025-03-10, with EUR 1,265 of buys and EUR 0 of sells, and the most common transaction nature is Acquisition.